Sarcoma  >>  buparlisib (AN2025)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
buparlisib (AN2025) / Adlai Nortye
NCT01468688: A Dose-finding Study of a Combination of Imatinib and BKM120 in the Treatment of 3rd Line GIST Patients

Completed
1
60
Europe, Canada, Japan, US
STI571, BKM120
Novartis Pharmaceuticals
3rd Line GIST
07/16
07/16

Download Options